-
Results of long-term study could help identify children at risk of future type 2 diabetes
Researchers at the University of Plymouth and Nestlé have revealed new insights into the factors that predispose children to developing type 2 diabetes in adult life.
-
International collaboration to advance policy into rare diseases
https://www.plymouth.ac.uk/news/international-collaboration-to-advance-policy-into-rare-diseases
Dr Konstantin Glebov is working with a European partner to take the next step in improving lives for people with rare diseases.
-
What can be done to tackle the GP shortage?
https://www.plymouth.ac.uk/news/pr-opinion/what-can-be-done-to-tackle-the-gp-shortage
As GP numbers continue to drop throughout the UK, experts explain what the University of Plymouth is doing to encourage more people into the career
-
Project aims to reduce the epilepsy risks for patients with intellectual disabilities
University of Plymouth news: Researchers from the University of Plymouth have led the development of the Clive Treacey Safety Checklist and accompanying guidance, which aim to provide practical advice for commissioning professionals.
-
The Hidden Disabilities Sunflower – Plymouth’s seedling idea that grew worldwide
University of Plymouth news: On the International Day of Persons with Disabilities, Ian Sherriff BEM reflects on the impact of the sunflower symbol he co-created with Gatwick Airport.
-
New research underlines need to be aware of loot box risks
https://www.plymouth.ac.uk/news/new-research-underlines-need-to-be-aware-of-loot-box-risks
University of Plymouth news: Now research led by the University has shown that at-risk individuals, such as those with known gaming and gambling problems, are more likely to engage with loot boxes
-
Chlorine disinfectant is no more effective than water at killing off superbug
University of Plymouth news: Research published during World Antimicrobial Awareness Week explores the impact of using chlorine chemicals to tackle Clostridioides difficile, the most common cause of antibiotic associated sickness in healthcare settings.
-
Could weight loss drug benefit patients living with alcohol addiction, liver disease and obesity?
University of Plymouth news: Our researchers are leading a new study testing if a weight loss drug already being used to treat obesity and diabetes could also benefit patients impacted by alcoholism and obesity, two of the biggest causes of liver disease
-
Research explores if artificial intelligence can support safer prescribing for people with intellectual disabilities and epilepsy
University of Plymouth - Research explores if artificial intelligence can support safer prescribing for people with intellectual disabilities and epilepsy
-
Spinout raises funding to accelerate tests for harmful bacteria
https://www.plymouth.ac.uk/news/spinout-raises-funding-to-accelerate-tests-for-harmful-bacteria
Molendotech, a University of Plymouth spinout company, has recently attracted strong interest internationally from potential customers concerned about secondary infections as they tackle the COVID-19 outbreak.
Filter results by
Displaying results 121 - 130 of 1810 in total